Guidance

Evidence-based recommendations on botulinum toxin type A injections into the urethral sphincter for idiopathic chronic non-obstructive urinary retention. This involves injecting botulinum toxin type A into the urethral sphincter.

Is this guidance up to date?

Next review: 2026

Guidance development process

How we develop NICE interventional procedures guidance

Coding and clinical classification codes for this guidance.

Endorsing bodies

This interventional procedures guidance is endorsed by Healthcare Improvement Scotland as required by the Health and Social Care Act (2012).

  • National Institute for Health and Care Excellence (NICE)